1.10317
Fractogel® EMD BioSEC (S)
Sinónimos:
Fractogel® EMD BioSEC (S)
About This Item
Productos recomendados
ligand
(Modified pore structure)
Quality Level
description
for size exclusion chromatography (SEC), suspension in 20% ethanol and 150 mM NaCl (20-40 µm)
product line
Fractogel®
parameter
100 cm/hr max. flow rate
8 bar pressure
matrix active group
Methacrylate
mean particle size
20-40 μm
transition temp
flash point 35 °C (calculated)
density
1.43 g/cm3 at 20 °C
application(s)
viral therapy
separation technique
size exclusion (SEC)
storage temp.
2-30°C
Categorías relacionadas
General description
Features and Benefits
- Effectively remove dimer and high molecular weight aggregates and complete an efficient polishing of blood plasma factors
- Determine apparent molecular weights of proteins
- Move predictably and efficiently from bench scale to manufacturing scale processing
- Create a robust, consistent, and transferable process
Packaging
Analysis Note
Microscopic evaluation: Uniform sphericalparticles, noagglomerates, nofines
Extractable matter (water): ≤ 0.03 %
Cerium: ≤ 1 µg/g
Pressure drop(column: ID=1.6 cm, L=10 cm at 5 ml/min): ≤ 5.0 bar
Particle size (d10): 20 - 28 µm
Particle size (d50): 24 - 34 µm
Particle size (d90): 28 - 38 µm
Colony forming units (TAMC + TYMC): ≤ 100 CFU/ml
Endotoxins: ≤ 1.00 EU/ml
Function test (b:a): ≤ 0.7
function test (c:d): ≤ 0.05
Functional Test: Separation of bovine serum albumin, ovalbumin and cytochrom C
Legal Information
Not finding the right product?
Try our Herramienta de selección de productos.
signalword
Warning
hcodes
Hazard Classifications
Flam. Liq. 3
Storage Class
3 - Flammable liquids
wgk_germany
WGK 3
flash_point_f
95.0 °F
flash_point_c
35 °C
Certificados de análisis (COA)
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Artículos
Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.
A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.
Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.
This technical article breaks down the steps of upstream and downstream bioprocessing and formulation of virus-like particle vaccines.
Contenido relacionado
This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico